Venous thromboembolism (VTE) -like deep vein thrombosis (DVT) and pulmonary embolism (PE) -is reported as a complication after radical prostatectomy (RP) in 0. .2% with the use of various prophylactic methods [1] . These thrombotic complications were the most common cause of death after oncological pelvic surgery according to a large population study with a ratio of 40% [2] . Guidelines were composed in order to prevent thrombotic events after surgical procedures, but these data are not supported by recent comparative studies concerning risk assessment and thrombosis prophylaxis of European centers performing RPs [3, 4] . The role and way of thrombosis prophylaxis is not included in the most important European urological guidelines [5] . A reason for this can be that there is still a lack of randomized trials comparing the different pharmacological interventions and ways of mechanic prophylaxis. The papers reporting the effects of thrombosis prophylaxis in urological surgery were published at least 20 years ago, and these publications do not provide information on low molecular weight heparin (LMWH) administration [6, 7] . The costeffectiveness of the different thromboprophylactic methods is also not evaluated regarding urological procedures.
Prophylaxis of DVT was proven cost-effective in terms of gained life-years according to a study of gynecologic procedures. External pneumatic compression appeared to be the most cost-effective strategy under the authors' baseline assumptions against LMWH and unfractionated heparin (UFH) [8] .
The guidelines of the American Urological Association recommend the following prophylaxis in urology related to laparoscopic and major open procedures after the determination of the individual thrombotic risk of the patient. Regarding laparoscopic procedures it is recommended to use pneumatic compression boots (PCBs) at the time of the surgical intervention. In high-risk and very-high-risk groups (like laparoscopic and open RPs) patients may require the use of low-dose UFH or LMWH, but a clear recommendation cannot be done regarding the use of pharmacological prophylaxis due to the lack of RCTs in this population. Given the increased risk factors within the patient population undergoing open urologic procedures, more aggressive regimens combining the use of PCBs with pharmacological prophylaxis may be considered [3, 9] . The recommendation is the following for open urological procedures: high-risk patients require UFH 3× or LMWH 1× daily or PCBs if bleeding is high, in case of very-high-risk patients UFH 3× and/or LMWH 1× daily and PCBs are recommended. In case of an increased risk of bleeding, mechanical prophylaxis is favored against pharmacological prophylaxis [3] .
The hypercoagulable state after RP was proven by a recent trial which can be a predictor of thrombotic events [10] . Since the second peak of thrombotic events is present in the 4th week after radical pelvic surgery, use of the prophylactic method should be considered till the end of the 1st postoperative month [2] .
The aims of the present study were to evaluate (a) the present practice of thrombosis prophylaxis, (b) the role of different prophylactic measures, and (c) the ratio of thrombotic events in Hungary in comparison with international practice. A further aim was to advise discussion points to a guideline development work.
Materials and Methods
A questionnaire was posted to every urology department (n = 37) actively performing such surgical procedures in Hungary. In a covering letter the head of the division was requested to report retrospectively the number of performed RPs, the preferred approach, the surgeons' experience, the length of the postoperative hospital stay, thrombotic risk assessment, the way and the length of different prophylactic methods and the number of experienced thrombotic events of the previous year. The responders were asked either to present their results by filling in the questionnaire electronically (http://urology.deoec.hu/info.aspx?sp = 10) or returning it by post. All data was entered into a computer database and analyzed in an anonymous fashion. Microsoft Office Excel statistics were used during the analysis.
The ethics committee of the Health Scientific Committee of the Ministry of Health approved the study protocol (case No. 24098-0/2010-1018EKU). The Hungarian Association of Urology morally supported the present research.
Results

Response Rate, Number and Approach of Radical Prostatectomies
A total response rate of 59% (22 departments) was achieved. Eight departments do not perform RP and were excluded from the present study. The reported number of RPs was 506 performed by the departments who filled in the form, among these were 41.9% (212) laparoscopic, 0.8% (4) perineal, and 57.3% (290) retropubic RPs. The highvolume centers (RPs >50/year) performed 314 RPs (62.1% of all) ( table 1 ). More than 70% of the procedures were performed by a single surgeon in 93% of the institutes. The average length of hospital stay was 10 days (range 8-16).
Risk Assessment and Way of Thrombosis Prophylaxis
Pharmacological thromboprophylaxis with LMWH once daily was preferred by 100% of the departments, but the practice was different ( table 2 ). 80% of the patients are under LMWH administration from the 1st day prior to RP to the end of the 4th postoperative week. None of the institutes reported the use of UFH. Graduated support stockings were applied by 37% of the patients. Although PCBs were available in 29% of the institutes, they were not used. Early mobilization was the most common way of mechanic prophylaxis. One low-volume department reported the method of planned hemodilution during the surgical procedure for the purpose of thrombosis prophylaxis. Although dose adjustment of LMWH is performed in 93% of the departments and by 91% of the patients, risk assessment was reported only by 11 institutes. In the high-volume centers this is the task of the anesthesiologist, but in the smaller institutes it is that of the urologist ( table 3 ) .
Modification of Ongoing Anticoagulant Treatment
Acetylsalicylic acid drugs were stopped by 97% of the patients (487), and in 58% (287) they were replaced by LMWH. In case of thienopyridines these drugs were switched to LMWH in 82% (416). Coumarins were replaced in 100%. The highest variation was experienced regarding the timing of modification of ongoing anticoagulant treatment of the patients. The responders reported stopping the therapy in the range of the 10th to the 1st day prior to surgery, and the drugs were re-administered in the range of the 1st to the 30th postoperative day.
Thrombotic Events
According to the self-report of the institutes, clinical thrombotic events were experienced in 1.4% of the cases (7 patients): 4 were DVT and 3 were PE. Two DVT events occurred during the 4th postoperative week, the others were experienced within 2 weeks after the surgical procedure. Two thrombotic events were reported by a highvolume center (>50 RPs/year) and two by a low-volume department (<20 RPs/year). Six patients were under constant LMWH prophylaxis at the time of the thrombotic event. The start of the pharmacological prophylaxis varied from 1 day prior to surgery to the 1st postoperative day. Graduated support stockings (GSS) were also applied in the first few postoperative days by 5 patients. Five patients underwent risk assessment and dose adjustment prior to surgery, 3 of them were rated as high-risk, the others as very-high-risk patients. One of the 7 events was fatal (0.2% referring to the whole study population) and this event was reported by a low-volume department (3 weeks of LMWH + GSS).
Limitations
The data entered by the responders regarding the thrombotic events were self-reported and could not be verified. There were some centers in Hungary that did not answer the questionnaire. PCBs available in the institute/hospital, but none were used. 
Discussion
The number of reported RPs represents the current practice in Hungary. The most experienced centers in the country prefer the laparoscopic approach. Since more than 70% of the procedures were performed by a single surgeon in 93% of the institutes, we were able to draw the conclusion that especially in the high-volume centers the surgeons are experienced enough where most of the patients were treated (62%), which is the most important factor regarding the oncological and functional outcome independent from the preferred approach [11, 12] . Experienced centers can even perform RP in selected locally advanced cases with satisfactory results [13] . Good surgeon skills can also decrease blood loss during RP so that the departments can better focus on thrombosis prophylaxis.
The most common method of prevention is pharmacological prophylaxis in the Hungarian hospitals studied, although the timing of LMWH administration is not unified. These results were similar to the practice of UK centers as reported by Galvin et al. [4] . In case of an increased risk of bleeding, pharmacological prophylaxis should be replaced by PCBs, what was not characteristic in the Hungarian departments. LMWH administration was stopped before the end of the 2nd week in almost 20% of the patients. According to different studies the risk of thrombotic events remains till at least the end of the 1st postoperative month [2, 10] . The role of different ways of mechanic prophylaxis was minor except the early mobilization. PCBs are available in almost 30% of the departments, but they do not use them -the reason why is yet to be evaluated.
The urologist determines the way and length of the thrombosis prophylaxis in 43% of the departments, therefore it is essential for the urological community to know the different methods, the presence of risk assessment and dose adjustment.
The majority of the departments had stopped any other anticoagulant therapy or prophylaxis before surgery, and many of them replaced it with LMWH. The timing varied considerably as the results show. Acetylsalicylic acid is for prevention and not for anticoagulant therapy, so it is not absolutely necessary to replace it [14] . Thienopyridines can lead to excessive bleeding during surgical procedures so it is recommended to replace them with LMWH 8 days before operation (the lifetime of thrombocytes is that long) and to switch back only when the risk of bleeding is over [15] . Perioperative antiplatelet drugs may not increase the risk of bleeding complications in urological surgery according to a recent metaanalysis, but still more high-quality trials with larger samples and longer follow-ups are required [16] .
The ratio of the reported thrombotic events is similar to the international results [1] . The fact that all 7 patients were administered LMWH and 6 of them were still protected by the drug raises the question whether pharmacological prophylaxis alone or in combination with early mobilization and GSS is appropriate for preventing VTE? Should urologists use PCBs in every case? These questions will remain unanswered till more papers are published regarding this topic, but as urologists it is essential to know the different prophylactic methods and to evaluate the effectiveness of the ones known. It would be beneficial if the European Association of Urology (EAU) Guidelines -which is a bible for all European urologists -would include recommendations of thrombosis prophylaxis in urology as is done by the American Urological Association [5] . An all-European study -or at least presented by each country -of the present practice of thrombosis prophylaxis would reveal the effectiveness of the different ways of prophylaxis.
Conclusion
Thrombosis prophylaxis of patients undergoing RP is not unified. Due to the potential mortality of thrombotic complications, as urologists it is essential to know the different prophylactic methods and to evaluate the effectiveness of the ones known. It would be beneficial that urological guidelines would include a chapter of thromboprophylaxis as well.
